Bioethics Grand Rounds
"Delivering Precision Medicine: The Role of
February 21, 2014
3:30 – 4:30 p.m.
Turner Auditorium, HSB D-209
special reception to follow in HSB A204
to honor Dr. Burke for her service as Chair
Molecular technologies and large scale data offer the promise of “precision medicine”
leading to a host of better diagnostic tools, prevention strategies, and disease treatments. But powerful technologies can produce harms as well as benefits. ristotle’s concept of phronesis – the practical wisdom acquired from experience and morally informed mentorship – can provide important guidance. Tapping the wisdom of clinicians and and patients will help to ensure that the tools of precision medicine are crafted and delivered in ways that support the fundamental goals of medicine.
This special edition of Bioethics Grand Rounds is given by Dr. Wylie Burke, Professor and former Chair of the Department of Bioethics and Humanities. Dr. Burke is also Principal Investigator of the Center for Genomics and Healthcare Equality, an NIH-funded Center of Excellence in Ethical, Legal, and Social Implications (ELSI) Research and Dual PI of the Northwest-Alaska Pharmacogenomics Research Network. Her research addresses the social, ethical and policy implications of genetic information.
Please join us in celebrating
Dr. Burke’s contributions to our department and UW Medicine.
We invite you to join us for Bioethics Grand Rounds, co-sponsored by the Department of Bioethics & Humanities and the Ethics Advisory Committee at the University of Washington Medical Center.
click here for flyer
Sign up to receive information about Bioethics Grand Rounds at the bioethics mailing list at https://mailman1.u.washington.edu/mailman/listinfo/bioethics.
||Wylie Burke, MD, PhD
||"Delivering Precision Medicine: The Role of
||Doug Opel, MD, MPH
||Shared Decisiion-Making in Medicine: A Decrepit Concept
||Panel Discussion w/ UW Ethics Advisory Committee:
Moderators: Laura Webster, RN MA and Jamie Shirley, RN, PhD
|The Capacity Conundrum: When Should We Compel Life-Sustaining Treatments Over the Objection of Incompetent Patients?
||Rebecca Levine, JD, MPH
||From Congress and Courts to the Bench and Bedside: Promoting Dialogue between the Health Care and Disability Communities
||Douglas S. Diekema, MD, MPH
Eyes Wide Open: Physician Relationship
with the Pharmaceutical Industry
||Sallie Thieme-Sanford, J.D.
The Supreme Court’s ACA Decision and “the neediest among us”
||Kelly Edwards, Ph.D.
"People Matter: Innovative Approaches to Engage Participants in Research"
||Michael J. Souter, M.B.Ch.B
||"Donation after Cardiac Death –Shades of Grey"
||John T. Slattery, Ph.D. and
S. Malia Fullerton, D.Phil
|“Promoting Responsible Collection and Use of Residual Clinical Specimens in Research:
the Washington Phenotyped Biospecimen Resource”
||J. Randall Curtis, MD, MPH
||"Integrating palliative and critical care: An empirical approach to providing ethical and high quality end-of-life care"
||Mark Tonelli, MD MA
||"The End of Evidence: The Ethics and Epistemology of Clinical Decision Making"
||Paul W. Zarutskie, MD
||"From Babies to Stem Cells: The Ethics of Reproductive Technologies"
||Denise M. Dudzinski, PhD MTS; Thomas Gallagher, MD;
Mary Beth Foglia, PhD RN
“Should hospitals disclose adverse events that might harm multiple patients?”
||James Gordon, MD, FRCPC, FAAN
"Neurological Enhancement and Moral Decision making in Medicine"
||Sarah E. Shannon, PhD, RN
||‘Why Do Families Request “Futile” Life-Sustaining Treatments?’
||Pat Kuszler, MD, JD and
Sallie Sanford, JD
|“How about Health Care Reform? What’s the Prognosis?”